Investing In The Biotechnology of Cannabis

Four world leaders in the clinical applications of cannabis take a deep dive into cannabinoid based drugs, IP, and the biotechnology of cannabis.

Matthew Callhan – Botanix Pharmaceuticals
Guy Chamberland – Tetra Bio-Pharma
John Docherty – Lexaria Biosciences
David Elsley – Cardiol Therapeutics
Moderated by Rahul Sarugaser – Paradigm Capital

Join us at an upcoming event!

Be part of our investment community:

Copyright © 2019 Cambridge House International Inc. All rights reserved.


%d bloggers like this: